Sanofi | SNY - Текущие активы





Текущие активы Изменить Дата
AbbVie USD 33.53B 4.47B 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
Glaxosmithkline GBP 17.76B 5.83B 2026-03
J&J USD 59.77B 601M 2026-06
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 27.35B 744M 2026-06
Novartis USD 26.61B 3.85B 2026-03
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Sanofi EUR 30.16B 789M 2026-03
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
UCB EUR 6.05B 733M 2025-12
Zoetis USD 6.47B 294M 2026-03